The role of aggressive corticosteroid therapy in patients with juvenile dermatomyositis: a propensity score analysis.
about
Developments in the classification and treatment of the juvenile idiopathic inflammatory myopathiesBiologic therapies for refractory juvenile dermatomyositis: five years of experience of the Childhood Arthritis and Rheumatology Research Alliance in North America.Protocols for the initial treatment of moderately severe juvenile dermatomyositis: results of a Children's Arthritis and Rheumatology Research Alliance Consensus Conference.Juvenile dermatomyositis: new developments in pathogenesis, assessment and treatment.Juvenile dermatomyositis: new insights and new treatment strategies.A robust in vitro screening assay to identify NF-kappaB inhibitors for inflammatory muscle diseases.Myositis registries and biorepositories: powerful tools to advance clinical, epidemiologic and pathogenic research.Clinical course and outcomes of Iranian children with juvenile dermatomyositis and polymyositis.Idiopathic Inflammatory Myopathies: an Update on Classification and Treatment with Special Focus on Juvenile Forms.Treatment of Juvenile Dermatomyositis: An Update.Cumulative organ damage and prognostic factors in juvenile dermatomyositis: a cross-sectional study median 16.8 years after symptom onset.Recent developments on treatment strategies and the prognosis of dermatomyositis: a review.Finger stiffness or edema as presenting symptoms of eosinophilic fasciitis.[Myositides: What is the current situation?].Therapeutic approaches in the treatment of juvenile dermatomyositis in patients with recent-onset disease and in those experiencing disease flare: An international multicenter PRINTO studyThe Vasculopathy of Juvenile Dermatomyositis
P2860
Q26863125-31D66620-CDFD-4A95-8430-E466DE2A1123Q33795594-EAEB8873-64E1-4773-BC5B-093167591B7DQ34019438-CC6FD9E8-B9C9-40F3-A43B-FB8E83B74C31Q35009335-FC5D840F-F90B-47C7-8049-3673C7706BB1Q36059542-3181B962-B88E-4A10-B95E-3C885CA42F1BQ37351313-1878A5DE-E14B-437F-A928-F0AC6B0EEBD0Q37368405-085B5CD1-C5BC-4DEE-8371-EC56141CCC4EQ38216182-2D61CD8D-BC7B-451E-B1E5-34A68D9EBA5EQ38597575-A9D24CF3-FF9C-4B4E-8361-3D36A7E5CD7EQ38678257-CC63E4C4-8470-4A76-BBAD-149DE73EEB26Q43863286-22BDED2A-9E9F-42F8-8B49-7D91A3913277Q47436112-756FFF9E-B15A-4DF3-8C55-F80A096EF98EQ53389623-EB23CCA3-3979-4516-A45D-EB80512F2251Q54258621-71FEAB52-2B33-4965-9F84-2012B09AB5E0Q56966414-1AB7D46D-5FB8-45B6-9279-C9814C8901A4Q57816912-29D1ACD0-23D9-4830-8E5F-5BD371ABA22F
P2860
The role of aggressive corticosteroid therapy in patients with juvenile dermatomyositis: a propensity score analysis.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
The role of aggressive cortico ...... : a propensity score analysis.
@ast
The role of aggressive cortico ...... : a propensity score analysis.
@en
type
label
The role of aggressive cortico ...... : a propensity score analysis.
@ast
The role of aggressive cortico ...... : a propensity score analysis.
@en
prefLabel
The role of aggressive cortico ...... : a propensity score analysis.
@ast
The role of aggressive cortico ...... : a propensity score analysis.
@en
P2093
P2860
P356
P1476
The role of aggressive cortico ...... s: a propensity score analysis
@en
P2093
Brian M Feldman
Gail Cawkwell
Lauren M Pachman
Roopa Seshadri
P2860
P304
P356
10.1002/ART.23829
P577
2008-07-01T00:00:00Z